Get the Stockscreener App
1.15
4.96%
-0.06
After Hours:
1.15
Creative Medical Technology Holdings Inc stock is traded at $1.15, with a volume of 921.14K.
It is down -4.96% in the last 24 hours and down -44.17% over the past month.
Creative Medical Technology Holdings Inc is a commercial-stage biotechnology company focused on the advancement of regenerative therapies in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics. Its pipeline consists of AlloStem (CELZ-201-DDT); ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, an intervention for the treatment of recent onset Type 1 Diabetes; AlloStemSpine for treatment of lower back pain; the Alova program to treat infertility as a result of premature ovarian failure; and other regenerative treatment programs and technologies like OvaStem, CaverStem, FemCelz, StemSpine, and others for the treatment of various indications related to sexual health, spine disc disease, kidney failure, liver failure, etc.
See More
Previous Close:
$1.21
Open:
$1.23
24h Volume:
921.14K
Relative Volume:
0.31
Market Cap:
$4.25M
Revenue:
$3,000
Net Income/Loss:
$-5.76M
P/E Ratio:
-0.6226
EPS:
-1.8471
Net Cash Flow:
$-5.59M
1W Performance:
+41.94%
1M Performance:
-44.17%
6M Performance:
-48.43%
1Y Performance:
-56.93%
1-Day Range:
$1.10
$1.23
1-Week Range:
$1.10
$4.7199
52-Week Range:
$0.7901
$6.25
Creative Medical Technology Holdings Inc Stock (CELZ) Company Profile
Name
Creative Medical Technology Holdings Inc
Sector
Industry
Phone
480-399-2822
Address
211 E. OSBORN RD., PHOENIX
Compare CELZ vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CELZ
Creative Medical Technology Holdings Inc
|
1.15 | 5.36M | 3,000 | -5.76M | -5.59M | -1.8471 |
VRTX
Vertex Pharmaceuticals Inc
|
529.59 | 126.07B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
649.81 | 65.37B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
916.80 | 57.70B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
313.04 | 40.19B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
189.99 | 39.82B | 742.00K | -1.37B | -1.07B | -7.0731 |
Creative Medical Technology Holdings Inc Stock (CELZ) Latest News
Creative Medical (CELZ) asks shareholders to OK 5.58M warrants, 100M cap increase - Stock Titan
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Creative Medical provides mid-year business update By Investing.com - Investing.com Australia
Creative Medical Technology Holdings Issues Mid-Year Update - marketscreener.com
Creative Medical says FDA-cleared pain trial is 85% enrolled - Stock Titan
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Why Constellation Brands Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
ADRMD Stock Price and Chart — OTC:ADRMD - TradingView
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Creative Medical secures $4.5M through warrant exercise deal - Investing.com
Creative Medical (CELZ) Secures $4.5M from Immediate Warrant Exe - GuruFocus
Creative Medical Technology Holdings Announces Immediate Exercise of Warrants for Approximately $4.5 Million in Gross Proceeds - Quiver Quantitative
Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.5 Million Gross Proceeds - The Manila Times
Creative Medical locks in $4.5M from warrant holders - Stock Titan
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
CELZ jumps before FDA update as traders weigh dilution math - TechStock²
Nasdaq Gains Over 300 Points; Chicago PMI Falls In June - Benzinga
Trending Stocks Today | Creative Medical Technology Shoots up 325.54% - Moomoo
Creative Medical Technology Holdings surges as traders appear to chase recent clinical and platform updates - Quiver Quantitative
CELZ Stock Jumps As FDA Clears Expanded Pain Trial - StocksToTrade
US Stocks Mixed; Home Prices Increase 1.1% In April - Benzinga
CELZ Stock Whipsaws As FDA Trial Expansion And AI Push Grab Attention - timothysykes.com
$Creative Medical Technology (CELZ.US)$ thank you that's a fast one. - Moomoo
[RW] CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. SEC Filing - Stock Titan
Nasdaq Falls Over 200 Points; US Goods Trade Gap Widens In May - Sahm
Creative Medical Technology Holdings, Inc. Actuals & Estimates (NASDAQ:CELZ) - TradingView
Form S-1/A Creative Medical Technology Holdings Inc For: 26 June By Investing.com - Investing.com Australia
[S-1/A] CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. Amends IPO Registration Statement - Stock Titan
Creative Medical Technology Holdings, Inc. Actuals & Estimates (BOATS:CELZ) - TradingView
These Three Stocks Fell More Than 10% Today To Hit 52-Week Lows -- What's Driving The Investor Skepticism? - TradingView
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Enterprise value to EBIT forward of Creative Medical Technology Holdings, Inc. – NASDAQ:CELZ - TradingView
Why Synaptics Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket - Benzinga
Creative Medical Files for Securities Offering - Moomoo
Creative Medical Technology Holdings Inc - TradingKey
CELZ Forecast — Price Target — Prediction for 2027 - TradingView
Creative Medical Technology Holdings Files to Offer Up 3.05M Shrs and Up to 6.09M Warrants - Moomoo
Number of shareholders of Creative Medical Technology Holdings, Inc. – NASDAQ:CELZ - TradingView
Price to sales forward of Creative Medical Technology Holdings, Inc. – NASDAQ:CELZ - TradingView
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Creative Medical (NASDAQ: CELZ) plans $5.3M stock and warrant raise - Stock Titan
FDA Clears Olastrocel Trial Expansion - Conexiant
Creative Medical (CELZ) Gains FDA Approval for Clinical Trial Ex - GuruFocus
FDA clears Creative Medical trial expansion for back pain therapy - Investing.com UK
FDA clears Creative Medical trial expansion for back pain therapy By Investing.com - Investing.com South Africa
Creative Medical Technology Holdings Announces FDA Clearance of Expanded ADAPT Trial Cohort for CELZ-201 in Chronic Lower Back Pain - Quiver Quantitative
Creative Medical gets FDA clearance to add 15 patients in Olastrocel trial - Stock Titan
Creative Medical Technology Holdings Expands ADAPT Trial Under New FDA Clearance and Rapidly Advances Toward Phase 3 Planning for Olastrocel in Chronic Lower Back Pain - The Manila Times
Creative Medical Technology Holdings Inc (CELZ) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Creative Medical Technology Holdings Inc (CELZ) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Creative Medical Technology Holdings Inc Stock (CELZ) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
0.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):